Drawing comparisons — How studying one ailment may solve another

Researchers are studying Chikungunya arthritis in hopes it will lead to treatments for patients suffering from rheumatoid arthritis, according to WNDU.com.

Advertisement

Here are four points:

1. By studying Chikungunya arthritis, researchers can learn more about the immunological mechanisms driving joint inflammation.

2. Researchers are comparing the white blood cells between Chikungunya patients and rheumatoid arthritis patients.

3. Both conditions lead to morning stiffness primarily affecting the joints in the hands, wrists, feet and ankles.

4. While Chikungunya can be cured, rheumatoid arthritis can only be treated.

More articles on quality & infection control:
Phoenix nonprofit receives $3.6M federal grant for healthcare improvement: 5 notes
Making varsity: Indiana University coaching physicians to improve care with $46M grant
CDC & FDA issues alert to healthcare facilities — 4 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.